Obesity drug developer Aardvark Therapeutics (AARD) has filed for a $100M initial public offering. Aardvark (AARD) didn't disclose any terms in its SEC filing, but indicated in its filing fee schedule ...

Companies may be going whale-hunting as the Trump administration aspires to loosen up regulations. "I think the regulatory ...

Brian McGill and Michael Hyser operate as Johns Creek Financial along with support-staff members Stacie Alexander and Alexis ...

Wells Fargo has recently reduced T-Mobile Us Inc (TMUS) stock to Equal Weight rating, as announced on January 6, 2025, according to Finviz. Earlier, on January 6, 2025, RBC Capital Mkts had reduced ...

Morgan Stanley will work with the U.S. Treasury and other regulators to figure out how it can offer crypto in a safe way ...

RBC BlueBay Asset Management’s hedge fund is seeing an opportunity to profit from volatility during US President Donald Trump’s second term, after outperforming the industry in a difficult period for ...

Dyne Therapeutics Inc (DYN) stock saw a modest uptick, ending the day at $14.55 which represents a slight increase of $0.42 or 2.97% from the prior close of $14.13. The stock opened at $14.3 and ...

In a report released yesterday, Deane Dray from RBC Capital maintained a Sell rating on 3M (MMM – Research Report), with a price target of ...

RBC Capital analyst Mandeep Jagpal maintained a Sell rating on abrdn (ABDN – Research Report) today and set a price target of p135.00. The ...

Underperforming since the calendar turned, "munis have continued to cheapen over the past three weeks as Treasury returns are about flat for the year while munis are down 0.31%," said Jason Wong, vice ...

Export Development Canada (EDC) stepped into the sterling on Monday to issue a new five year benchmark. “This was a good ...

RBC Capital Markets analyst Maurice Choy identifies relative “safer havens” in the yield-heavy energy infrastructure sector, ...